Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 542

1.

Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion.

Bom MJ, van Diemen PA, Driessen RS, Everaars H, Schumacher SP, Wijmenga JT, Raijmakers PG, van de Ven PM, Lammertsma AA, van Rossum AC, Knuuti J, Danad I, Knaapen P.

Eur Heart J Cardiovasc Imaging. 2019 Oct 16. pii: jez258. doi: 10.1093/ehjci/jez258. [Epub ahead of print]

PMID:
31620792
2.

Repeated oral glucose tolerance tests in women at risk for gestational diabetes mellitus.

de Wit L, Bos DM, van Rossum AP, van Rijn BB, Boers KE.

Eur J Obstet Gynecol Reprod Biol. 2019 Nov;242:79-85. doi: 10.1016/j.ejogrb.2019.09.022. Epub 2019 Sep 23.

PMID:
31569028
3.

Relationship between Extent of Ischaemic Burden and Changes in Absolute Myocardial Perfusion after Chronic Total Occlusion Percutaneous Coronary Intervention.

Schumacher SP, Kockx M, Stuijfzand WJ, Driessen RS, van Diemen PA, Bom MJ, Everaars H, Raijmakers PG, Boellaard R, van Rossum AC, Opolski MP, Nap A, Knaapen P.

EuroIntervention. 2019 Sep 24. pii: EIJ-D-19-00631. doi: 10.4244/EIJ-D-19-00631. [Epub ahead of print]

4.

Cardiac Magnetic Resonance for Evaluating Nonculprit Lesions After Myocardial Infarction: Comparison With Fractional Flow Reserve.

Everaars H, van der Hoeven NW, Janssens GN, van Leeuwen MA, van Loon RB, Schumacher SP, Demirkiran A, Hofman MBM, van der Geest RJ, van de Ven PM, Götte MJ, van Rossum AC, van Royen N, Nijveldt R.

JACC Cardiovasc Imaging. 2019 Sep 12. pii: S1936-878X(19)30731-4. doi: 10.1016/j.jcmg.2019.07.019. [Epub ahead of print]

PMID:
31542525
5.

Hemodynamic Optimization in Cardiac Resynchronization Therapy: Should We Aim for dP/dtmax or Stroke Work?

Zweerink A, Salden OAE, van Everdingen WM, de Roest GJ, van de Ven PM, Cramer MJ, Doevendans PA, van Rossum AC, Vernooy K, Prinzen FW, Meine M, Allaart CP.

JACC Clin Electrophysiol. 2019 Sep;5(9):1013-1025. doi: 10.1016/j.jacep.2019.05.020. Epub 2019 Jul 31.

PMID:
31537329
6.

1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction.

Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman Y, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

JACC Cardiovasc Interv. 2019 Aug 27. pii: S1936-8798(19)31533-X. doi: 10.1016/j.jcin.2019.07.018. [Epub ahead of print]

PMID:
31488353
7.

Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysis.

Achten NB, Klingenberg C, Benitz WE, Stocker M, Schlapbach LJ, Giannoni E, Bokelaar R, Driessen GJA, Brodin P, Uthaya S, van Rossum AMC, Plötz FB.

JAMA Pediatr. 2019 Sep 3. doi: 10.1001/jamapediatrics.2019.2825. [Epub ahead of print]

PMID:
31479103
8.

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.

Baird RD, van Rossum AGJ, Oliveira M, Beelen K, Gao M, Schrier M, Mandjes IAM, Garcia-Corbacho J, Vallier AL, Dougall G, van Werkhoven E, Linossi C, Kumar S, van Tinteren H, Callari M, Beddowes E, Perez-Garcia JM, Rosing H, Platte E, Nederlof P, Schot M, de Vries Schultink A, Bernards R, Saura C, Gallagher W, Cortès J, Caldas C, Linn SC.

Clin Cancer Res. 2019 Aug 22. doi: 10.1158/1078-0432.CCR-19-0508. [Epub ahead of print]

PMID:
31439579
9.

Adverse Plaque Characteristics Relate More Strongly With Hyperemic Fractional Flow Reserve and Instantaneous Wave-Free Ratio Than With Resting Instantaneous Wave-Free Ratio.

Driessen RS, de Waard GA, Stuijfzand WJ, Raijmakers PG, Danad I, Bom MJ, Min JK, Leipsic JA, Ahmadi A, van de Ven PM, Knuuti J, van Rossum AC, Davies JE, van Royen N, Narula J, Knaapen P.

JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30589-3. doi: 10.1016/j.jcmg.2019.06.013. [Epub ahead of print]

PMID:
31422133
10.

Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Comined Post- and Precapillay Pulmonary Hypertension.

Huis In't Veld AE, Oosterveer FPT, De Man FS, Marcus JT, Nossent EJ, Boonstra A, Van Rossum ACB, Vonk Noordegraaf A, Bogaard HJ, Handoko ML.

J Card Fail. 2019 Aug 5. pii: S1071-9164(18)31294-6. doi: 10.1016/j.cardfail.2019.07.547. [Epub ahead of print]

PMID:
31394199
11.

Building a Professional Identity and an Academic Career Track in Translational Medicine.

van Dijk SJ, Domenighetti AA, Gomez-Ospina N, Hunter P, Lindemans CA, Melotte V, van Rossum AMC, Rosenblum ND.

Front Med (Lausanne). 2019 Jul 3;6:151. doi: 10.3389/fmed.2019.00151. eCollection 2019.

12.

Continuous thermodilution to assess absolute flow and microvascular resistance: validation in humans using [15O]H2O positron emission tomography.

Everaars H, de Waard GA, Schumacher SP, Zimmermann FM, Bom MJ, van de Ven PM, Raijmakers PG, Lammertsma AA, Götte MJ, van Rossum AC, Kurata A, Marques KMJ, Pijls NHJ, van Royen N, Knaapen P.

Eur Heart J. 2019 Jul 21;40(28):2350-2359. doi: 10.1093/eurheartj/ehz245.

PMID:
31327012
13.

Impact of scan quality on the diagnostic performance of CCTA, SPECT, and PET for diagnosing myocardial ischemia defined by fractional flow reserve.

van Diemen PA, Driessen RS, Stuijfzand WJ, Raijmakers PG, Schumacher SP, Bom MJ, Everaars H, Min JK, Leipsic JA, Knuuti J, Underwood SR, van de Ven PM, van Rossum AC, Danad I, Knaapen P.

J Cardiovasc Comput Tomogr. 2019 Jun 12. pii: S1934-5925(19)30029-2. doi: 10.1016/j.jcct.2019.06.007. [Epub ahead of print]

PMID:
31302028
14.

The association of coronary lumen volume to left ventricle mass ratio with myocardial blood flow and fractional flow reserve.

van Diemen PA, Schumacher SP, Bom MJ, Driessen RS, Everaars H, Stuijfzand WJ, Raijmakers PG, van de Ven PM, Min JK, Leipsic JA, Knuuti J, Boellaard PR, Taylor CA, van Rossum AC, Danad I, Knaapen P.

J Cardiovasc Comput Tomogr. 2019 Jul - Aug;13(4):179-187. doi: 10.1016/j.jcct.2019.06.016. Epub 2019 Jun 24.

PMID:
31302027
15.

The Benefit of Prophylactic Implantable Cardioverter Defibrillator Implantation in Asymptomatic Heart Failure Patients With a Reduced Ejection Fraction.

van der Lingen ACJ, Timmer SAJ, Allaart LJH, Rijnierse MT, van de Ven PM, van Rossum AC, Kemme MJB, van Halm VP, Allaart CP.

Am J Cardiol. 2019 Aug 15;124(4):560-566. doi: 10.1016/j.amjcard.2019.05.026. Epub 2019 May 29.

16.

Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells.

Meyer Sauteur PM, Seiler M, Trück J, Unger WWJ, Paioni P, Relly C, Staubli G, Haas T, Gysin C, M Bachmann L, van Rossum AMC, Berger C.

Am J Respir Crit Care Med. 2019 Oct 15;200(8):1066-1069. doi: 10.1164/rccm.201904-0860LE. No abstract available.

PMID:
31251669
17.

Biomarkers for Infection in Children: Current Clinical Practice and Future Perspectives.

Stol K, Nijman RG, van Herk W, van Rossum AMC.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S7-S13. doi: 10.1097/INF.0000000000002318.

PMID:
31205237
18.

Introduction.

Curtis N, Finn A, Warris A, Pollard AJ, van Rossum A, Ramilo O.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S1. doi: 10.1097/INF.0000000000002316. No abstract available.

PMID:
31205235
19.

Cardiovascular magnetic resonance techniques for tissue characterization after acute myocardial injury.

Demirkiran A, Everaars H, Amier RP, Beijnink C, Bom MJ, Götte MJW, van Loon RB, Selder JL, van Rossum AC, Nijveldt R.

Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):723-734. doi: 10.1093/ehjci/jez094.

PMID:
31131401
20.

Adenosine single-photon emission computed tomography-derived transient ischemic dilatation and ejection fraction reserve fail to predict multivessel coronary artery disease.

Driessen RS, Raijmakers PG, Danad I, Stuijfzand WJ, Schumacher SP, Lammertsma AA, van Rossum AC, van Royen N, Underwood SR, Knaapen P.

Nucl Med Commun. 2019 Jul;40(7):773-774. doi: 10.1097/MNM.0000000000001033.

PMID:
31107409
21.

In-vivo validation of interpolation-based phase offset correction in cardiovascular magnetic resonance flow quantification: a multi-vendor, multi-center study.

Hofman MBM, Rodenburg MJA, Markenroth Bloch K, Werner B, Westenberg JJM, Valsangiacomo Buechel ER, Nijveldt R, Spruijt OA, Kilner PJ, van Rossum AC, Gatehouse PD.

J Cardiovasc Magn Reson. 2019 May 20;21(1):30. doi: 10.1186/s12968-019-0538-3.

22.

Myocardial Blood Flow and Coronary Flow Reserve During 3 Years Following Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent Implantation: The VANISH Trial.

Stuijfzand WJ, Schumacher SP, Driessen RS, Lammertsma AA, Bakker AL, Rijnierse MT, van Rossum AC, van de Ven PM, Nap A, Appelman Y, van Royen N, van Leeuwen MA, Lemkes JS, Raijmakers PG, Knaapen P.

JACC Cardiovasc Interv. 2019 May 27;12(10):967-979. doi: 10.1016/j.jcin.2019.03.004. Epub 2019 Apr 24.

PMID:
31029616
23.

A Patient With Multiorgan Failure and Fusiform Rod-Shaped Bacteria in the Blood Smear.

Claessen KMJA, van Rossum AP, Bolleboom IMCE, van 't Wout JW, Dennesen PJW.

Clin Infect Dis. 2018 Sep 14;67(7):1139-1141. doi: 10.1093/cid/ciy101. No abstract available.

PMID:
30986294
24.

Expert panel diagnosis demonstrated high reproducibility as reference standard in infectious diseases.

van Houten CB, Naaktgeboren CA, Ashkenazi-Hoffnung L, Ashkenazi S, Avis W, Chistyakov I, Corigliano T, Galetto A, Gangoiti I, Gervaix A, Glikman D, Ivaskeviciene I, Kuperman AA, Lacroix L, Loeffen Y, Luterbacher F, Meijssen CB, Mintegi S, Nasrallah B, Papan C, van Rossum AMC, Rudolph H, Stein M, Tal R, Tenenbaum T, Usonis V, de Waal W, Weichert S, Wildenbeest JG, de Winter-de Groot KM, Wolfs TFW, Mastboim N, Gottlieb TM, Cohen A, Oved K, Eden E, Feigin PD, Shani L, Bont LJ; IMPRIND consortium.

J Clin Epidemiol. 2019 Aug;112:20-27. doi: 10.1016/j.jclinepi.2019.03.010. Epub 2019 Mar 28.

PMID:
30930247
25.

Correction to: Extra energy for hearts with a genetic defect: ENERGY trial.

van Driel BO, van Rossum AC, Michels M, Huurman R, van der Velden J.

Neth Heart J. 2019 Apr;27(4):206-207. doi: 10.1007/s12471-019-1263-0.

26.

Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy.

Parbhudayal RY, Güçlü A, Zweerink A, Biesbroek PS, Croisille P, Clarysse P, Michels M, Stooker W, Vonk ABA, van der Ven PM, van Rossum AC, van der Velden J, Nijveldt R.

Int J Cardiovasc Imaging. 2019 Jun;35(6):1089-1100. doi: 10.1007/s10554-019-01563-3. Epub 2019 Mar 1.

27.

Extra energy for hearts with a genetic defect: ENERGY trial.

van Driel BO, van Rossum AC, Michels M, Huurman R, van der Velden J.

Neth Heart J. 2019 Apr;27(4):200-205. doi: 10.1007/s12471-019-1239-0. Erratum in: Neth Heart J. 2019 Mar 20;:.

28.

[Hypertrophic cardiomyopathy].

van Driel B, Asselbergs FW, de Boer RA, van Rossum AC, van Tintelen JP, van der Velden J, Michels M.

Ned Tijdschr Geneeskd. 2019 Feb 7;163. pii: D2790. Dutch.

PMID:
30730688
29.

Correction to: A mobile one-lead ECG device incorporated in a symptom-driven remote arrhythmia monitoring program. The first 5,982 Hartwacht ECGs.

Selder JL, Breukel L, Blok S, van Rossum AC, Tulevski II, Allaart CP.

Neth Heart J. 2019 Mar;27(3):165. doi: 10.1007/s12471-019-1225-6.

30.

Comparison of Coronary Computed Tomography Angiography, Fractional Flow Reserve, and Perfusion Imaging for Ischemia Diagnosis.

Driessen RS, Danad I, Stuijfzand WJ, Raijmakers PG, Schumacher SP, van Diemen PA, Leipsic JA, Knuuti J, Underwood SR, van de Ven PM, van Rossum AC, Taylor CA, Knaapen P.

J Am Coll Cardiol. 2019 Jan 22;73(2):161-173. doi: 10.1016/j.jacc.2018.10.056.

PMID:
30654888
31.

Impact of individualized segmentation on diagnostic performance of quantitative positron emission tomography for haemodynamically significant coronary artery disease.

Bom MJ, Schumacher SP, Driessen RS, Raijmakers PG, Everaars H, van Diemen PA, Lammertsma AA, van de Ven PM, van Rossum AC, Knuuti J, Mäki M, Danad I, Knaapen P.

Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):525-532. doi: 10.1093/ehjci/jey201.

PMID:
30590493
32.

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease.

Bom MJ, Levin E, Driessen RS, Danad I, Van Kuijk CC, van Rossum AC, Narula J, Min JK, Leipsic JA, Belo Pereira JP, Taylor CA, Nieuwdorp M, Raijmakers PG, Koenig W, Groen AK, Stroes ESG, Knaapen P.

EBioMedicine. 2019 Jan;39:109-117. doi: 10.1016/j.ebiom.2018.12.033. Epub 2018 Dec 23.

33.

Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel.

van Leeuwen MAH, van der Hoeven NW, Janssens GN, Everaars H, Nap A, Lemkes JS, de Waard GA, van de Ven PM, van Rossum AC, Ten Cate TJF, Piek JJ, von Birgelen C, Escaned J, Valgimigli M, Diletti R, Riksen NP, van Mieghem NM, Nijveldt R, van Royen N.

Circulation. 2019 Jan 29;139(5):636-646. doi: 10.1161/CIRCULATIONAHA.118.035931.

PMID:
30586720
34.

Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome.

Zweerink A, Friedman DJ, Klem I, van de Ven PM, Vink C, Biesbroek PS, Hansen SM, Emerek K, Kim RJ, van Rossum AC, Atwater BD, Nijveldt R, Allaart CP.

Circ Arrhythm Electrophysiol. 2018 Dec;11(12):e006767. doi: 10.1161/CIRCEP.118.006767.

PMID:
30541355
35.

A mobile one-lead ECG device incorporated in a symptom-driven remote arrhythmia monitoring program. The first 5,982 Hartwacht ECGs.

Selder JL, Breukel L, Blok S, van Rossum AC, Tulevski II, Allaart CP.

Neth Heart J. 2019 Jan;27(1):38-45. doi: 10.1007/s12471-018-1203-4. Erratum in: Neth Heart J. 2019 Mar;27(3):165.

36.

Elevated monocyte-specific type I interferon signalling correlates positively with cardiac healing in myocardial infarct patients but interferon alpha application deteriorates myocardial healing in rats.

Ter Horst EN, Krijnen PAJ, Hakimzadeh N, Robbers LFHJ, Hirsch A, Nijveldt R, Lommerse I, Fontijn RD, Meinster E, Delewi R, van Royen N, Zijlstra F, van Rossum AC, van der Schoot CE, van der Pouw Kraan TCTM, Horrevoets AJ, van der Laan AM, Niessen HWM, Piek JJ.

Basic Res Cardiol. 2018 Nov 12;114(1):1. doi: 10.1007/s00395-018-0709-7.

37.

Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions.

Schumacher SP, Driessen RS, Stuijfzand WJ, Raijmakers PG, Danad I, Dens J, Spratt JC, Hanratty CG, Walsh SJ, Boellaard R, van Rossum AC, Opolski MP, Nap A, Knaapen P.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1059-1066. doi: 10.1002/ccd.27945. Epub 2018 Nov 15.

38.

Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Meyer Sauteur PM, de Bruijn ACJM, Graça C, Tio-Gillen AP, Estevão SC, Hoogenboezem T, Hendriks RW, Berger C, Jacobs BC, van Rossum AMC, Huizinga R, Unger WWJ.

Infect Immun. 2019 Jan 24;87(2). pii: e00663-18. doi: 10.1128/IAI.00663-18. Print 2019 Feb.

39.

Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.

Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman YEA, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

Eur Heart J. 2019 Jan 14;40(3):283-291. doi: 10.1093/eurheartj/ehy651.

PMID:
30371767
40.

Chronotropic Incompetence in Chronic Heart Failure.

Zweerink A, van der Lingen ACJ, Handoko ML, van Rossum AC, Allaart CP.

Circ Heart Fail. 2018 Aug;11(8):e004969. doi: 10.1161/CIRCHEARTFAILURE.118.004969. Review.

PMID:
30354566
41.

Doppler Flow Velocity and Thermodilution to Assess Coronary Flow Reserve: A Head-to-Head Comparison With [15O]H2O PET.

Everaars H, de Waard GA, Driessen RS, Danad I, van de Ven PM, Raijmakers PG, Lammertsma AA, van Rossum AC, Knaapen P, van Royen N.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2044-2054. doi: 10.1016/j.jcin.2018.07.011. Epub 2018 Sep 26.

PMID:
30268877
42.

Priority Needs for Conducting Pandemic-relevant Clinical Research With Children in Europe: A Consensus Study With Pediatric Clinician-researchers.

Gal M, Gobat N, Francis NA, Hood K, Butler CC, Bielicki J, Fraaij PL, Sharland M, Jarvis J, van Rossum AMC, Heikkinen T, Martinon-Torres F, Herberg J, Watkins A, Webb SAR, Moore R, Sukumar P, Nichol A.

Pediatr Infect Dis J. 2019 May;38(5):e82-e86. doi: 10.1097/INF.0000000000002204.

43.

Diagnostic value of longitudinal flow gradient for the presence of haemodynamically significant coronary artery disease.

Bom MJ, Driessen RS, Raijmakers PG, Everaars H, Lammertsma AA, van Rossum AC, van Royen N, Knuuti J, Mäki M, Danad I, Knaapen P.

Eur Heart J Cardiovasc Imaging. 2019 Jan 1;20(1):21-30. doi: 10.1093/ehjci/jey129.

PMID:
30212851
44.

Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.

Parbhudayal RY, Garra AR, Götte MJW, Michels M, Pei J, Harakalova M, Asselbergs FW, van Rossum AC, van der Velden J, Kuster DWD.

J Mol Cell Cardiol. 2018 Oct;123:59-63. doi: 10.1016/j.yjmcc.2018.08.023. Epub 2018 Aug 28.

45.

The Art and Science of Diagnosing Mycoplasma pneumoniae Infection.

Meyer Sauteur PM, Unger WWJ, van Rossum AMC, Berger C.

Pediatr Infect Dis J. 2018 Nov;37(11):1192-1195. doi: 10.1097/INF.0000000000002171. Review. No abstract available.

PMID:
30169485
46.

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

van Rossum AGJ, Kok M, van Werkhoven E, Opdam M, Mandjes IAM, van Leeuwen-Stok AE, van Tinteren H, Imholz ALT, Portielje JEA, Bos MMEM, van Bochove A, Wesseling J, Rutgers EJ, Linn SC, Oosterkamp HM; MATADOR Trialists' Group.

Eur J Cancer. 2018 Oct;102:40-48. doi: 10.1016/j.ejca.2018.07.013.

47.

StemBell therapy stabilizes atherosclerotic plaques after myocardial infarction.

Woudstra L, Meinster E, VAN Haren L, Kay AM, Koopman M, Belien JAM, Morrison MC, VAN Rossum AC, Helder MN, Juffermans LJM, Niessen HWM, Krijnen PAJ.

Cytotherapy. 2018 Sep;20(9):1143-1154. doi: 10.1016/j.jcyt.2018.05.006. Epub 2018 Aug 12.

PMID:
30107976
48.

Percutaneous Coronary Intervention of Chronic Total Occlusions: When and How to Treat.

Schumacher SP, Stuijfzand WJ, Opolski MP, van Rossum AC, Nap A, Knaapen P.

Cardiovasc Revasc Med. 2019 Jun;20(6):513-522. doi: 10.1016/j.carrev.2018.07.025. Epub 2018 Aug 1. Review.

49.

Atrioventricular optimization in cardiac resynchronization therapy with quadripolar leads: should we optimize every pacing configuration including multi-point pacing?

van Everdingen WM, Zweerink A, Salden OAE, Cramer MJ, Doevendans PA, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

Europace. 2019 Jan 1;21(1):e11-e19. doi: 10.1093/europace/euy138.

PMID:
30052906
50.

Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques.

Zweerink A, van Everdingen WM, Nijveldt R, Salden OAE, Meine M, Maass AH, Vernooy K, de Lange FJ, Vos MA, Croisille P, Clarysse P, Geelhoed B, Rienstra M, van Gelder IC, van Rossum AC, Cramer MJ, Allaart CP.

ESC Heart Fail. 2018 Dec;5(6):1130-1140. doi: 10.1002/ehf2.12335. Epub 2018 Jul 26.

Supplemental Content

Loading ...
Support Center